Literature DB >> 33603227

Inflammasomes and adaptive immune responses.

Katherine A Deets1, Russell E Vance2,3,4.   

Abstract

A fundamental concept in immunology is that the innate immune system initiates or instructs downstream adaptive immune responses. Inflammasomes are central players in innate immunity to pathogens, but how inflammasomes shape adaptive immunity is complex and relatively poorly understood. Here we highlight recent work on the interplay between inflammasomes and adaptive immunity. We address how inflammasome-dependent release of cytokines and antigen activates, shapes or even inhibits adaptive immune responses. We consider how distinct tissue or cellular contexts may alter the effects of inflammasome activation on adaptive immunity and how this contributes to beneficial or detrimental outcomes in infectious diseases, cancer and autoimmunity. We aspire to provide a framework for thinking about inflammasomes and their connection to the adaptive immune response.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33603227     DOI: 10.1038/s41590-021-00869-6

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  174 in total

Review 1.  Inflammasome Complexes: Emerging Mechanisms and Effector Functions.

Authors:  Vijay A K Rathinam; Katherine A Fitzgerald
Journal:  Cell       Date:  2016-05-05       Impact factor: 41.582

Review 2.  Inflammasomes: mechanism of assembly, regulation and signalling.

Authors:  Petr Broz; Vishva M Dixit
Journal:  Nat Rev Immunol       Date:  2016-06-13       Impact factor: 53.106

Review 3.  Control of adaptive immunity by the innate immune system.

Authors:  Akiko Iwasaki; Ruslan Medzhitov
Journal:  Nat Immunol       Date:  2015-04       Impact factor: 25.606

Review 4.  Inflammatory cytokines as a third signal for T cell activation.

Authors:  Julie M Curtsinger; Matthew F Mescher
Journal:  Curr Opin Immunol       Date:  2010-04-02       Impact factor: 7.486

Review 5.  Innate Control of Adaptive Immunity: Beyond the Three-Signal Paradigm.

Authors:  Aakanksha Jain; Chandrashekhar Pasare
Journal:  J Immunol       Date:  2017-05-15       Impact factor: 5.422

6.  Caspase-8 as an Effector and Regulator of NLRP3 Inflammasome Signaling.

Authors:  Christina Antonopoulos; Hana M Russo; Caroline El Sanadi; Bradley N Martin; Xiaoxia Li; William J Kaiser; Edward S Mocarski; George R Dubyak
Journal:  J Biol Chem       Date:  2015-06-22       Impact factor: 5.157

7.  ASC is an activating adaptor for NF-kappa B and caspase-8-dependent apoptosis.

Authors:  Junya Masumoto; Theresa A Dowds; Philip Schaner; Felicia F Chen; Yasunori Ogura; Mu Li; Li Zhu; Tsutomu Katsuyama; Junji Sagara; Shun'ichiro Taniguchi; Deborah L Gumucio; Gabriel Núñez; Naohiro Inohara
Journal:  Biochem Biophys Res Commun       Date:  2003-03-28       Impact factor: 3.575

Review 8.  How Inflammasomes Inform Adaptive Immunity.

Authors:  Charles L Evavold; Jonathan C Kagan
Journal:  J Mol Biol       Date:  2017-10-05       Impact factor: 5.469

Review 9.  B Cell Responses: Cell Interaction Dynamics and Decisions.

Authors:  Jason G Cyster; Christopher D C Allen
Journal:  Cell       Date:  2019-04-18       Impact factor: 41.582

10.  Salmonella infection induces recruitment of Caspase-8 to the inflammasome to modulate IL-1β production.

Authors:  Si Ming Man; Panagiotis Tourlomousis; Lee Hopkins; Tom P Monie; Katherine A Fitzgerald; Clare E Bryant
Journal:  J Immunol       Date:  2013-10-11       Impact factor: 5.422

View more
  30 in total

Review 1.  Lipid-protein interactions regulating the canonical and the non-canonical NLRP3 inflammasome.

Authors:  Malvina Pizzuto; Pablo Pelegrin; Jean-Marie Ruysschaert
Journal:  Prog Lipid Res       Date:  2022-07-25       Impact factor: 14.673

Review 2.  Pyroptosis and Its Role in Autoimmune Disease: A Potential Therapeutic Target.

Authors:  Ruixuan You; Xinglan He; Zhuotong Zeng; Yi Zhan; Yangfan Xiao; Rong Xiao
Journal:  Front Immunol       Date:  2022-05-25       Impact factor: 8.786

Review 3.  Diabetes Mellitus Promotes the Development of Atherosclerosis: The Role of NLRP3.

Authors:  Jingxue Ye; Lanfang Li; Min Wang; Qiuxiao Ma; Yu Tian; Qiong Zhang; Jiushi Liu; Bin Li; Bengang Zhang; Haitao Liu; Guibo Sun
Journal:  Front Immunol       Date:  2022-06-29       Impact factor: 8.786

4.  Caspase-11 interaction with NLRP3 potentiates the noncanonical activation of the NLRP3 inflammasome.

Authors:  Julien Moretti; Baosen Jia; Zachary Hutchins; Soumit Roy; Hilary Yip; Jiahui Wu; Meimei Shan; Samie R Jaffrey; Jörn Coers; J Magarian Blander
Journal:  Nat Immunol       Date:  2022-04-29       Impact factor: 31.250

Review 5.  Molecular mechanisms and functions of pyroptosis in inflammation and antitumor immunity.

Authors:  Junwei Hou; Jung-Mao Hsu; Mien-Chie Hung
Journal:  Mol Cell       Date:  2021-09-24       Impact factor: 17.970

Review 6.  Salmonella Typhimurium and inflammation: a pathogen-centric affair.

Authors:  Jorge E Galán
Journal:  Nat Rev Microbiol       Date:  2021-05-19       Impact factor: 78.297

7.  Assessing the Association of Mitochondrial Function and Inflammasome Activation in Murine Macrophages Exposed to Select Mitotoxic Tri-Organotin Compounds.

Authors:  Gabrielle M Childers; Caroline A Perry; Barbara Blachut; Negin Martin; Carl D Bortner; Stella Sieber; Jian-Liang Li; Michael B Fessler; G Jean Harry
Journal:  Environ Health Perspect       Date:  2021-04-30       Impact factor: 9.031

8.  NLRC4 inhibits NLRP3 inflammasome and abrogates effective antifungal CD8+ T cell responses.

Authors:  Camila O S Souza; Natália Ketelut-Carneiro; Cristiane M Milanezi; Lúcia H Faccioli; Luiz G Gardinassi; João S Silva
Journal:  iScience       Date:  2021-05-18

Review 9.  Microglia in Neurodegenerative Events-An Initiator or a Significant Other?

Authors:  Gaylia Jean Harry
Journal:  Int J Mol Sci       Date:  2021-05-29       Impact factor: 5.923

10.  Molecular Mechanisms of the Toll-Like Receptor, STING, MAVS, Inflammasome, and Interferon Pathways.

Authors:  Nathan P Manes; Aleksandra Nita-Lazar
Journal:  mSystems       Date:  2021-06-29       Impact factor: 6.496

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.